title: Biological effects of MC2050, a quinazoline-based PARP-1 inhibitor, in human neuroblastoma and EBV-positive Burkitt's lymphoma cells.
authors.affiliation: Department of Biochemical Sciences, "Sapienza" University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy. luciana.mosca@uniroma1.it
authors.forename: Luciana
authors.initials: L
authors.lastname: Mosca
authors.forename: Dante
authors.initials: D
authors.lastname: Rotili
authors.forename: Italo
authors.initials: I
authors.lastname: Tempera
authors.forename: Alessandra
authors.initials: A
authors.lastname: Masci
authors.forename: Mario
authors.initials: M
authors.lastname: Fontana
authors.forename: Roberta
authors.initials: R
authors.lastname: Chiaraluce
authors.forename: Paola
authors.initials: P
authors.lastname: Mastromarino
authors.forename: Maria
authors.initials: M
authors.lastname: d'Erme
authors.forename: Antonello
authors.initials: A
authors.lastname: Mai
mesh_terms: D002051:Burkitt Lymphoma / Q000378:metabolism / Q000473:pathology; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D004854:Herpesvirus 4, Human / Q000187:drug effects* / Q000254:growth & development / Q000378:metabolism; D006801:Humans; D009447:Neuroblastoma / Q000378:metabolism / Q000473:pathology; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D011799:Quinazolines / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
chemical_list: D004791:Enzyme Inhibitors; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D011799:Quinazolines